Prevention of oxidative DNA damage in inner organs and lymphocytes of rats by green tea extract. 2010

Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.

BACKGROUND Consumption of green tea (GT) is associated with decreased incidences of specific forms of cancer in humans and it was postulated that its antioxidant (AO) properties may account for these effects. The evidence for AO effects of GT is mainly based on the results from in vitro experiments and on animal studies in which protection against chemically induced damage was monitored. OBJECTIVE The goal of the study was the investigation of the prevention of strand breaks and DNA migration attributable to endogenous oxidation of bases by GT extract (GTE) in inner organs and lymphocytes of untreated rats. In addition, immunological parameters and biochemical markers were monitored. METHODS DNA migration was measured in hepatocytes, colonocytes and lymphocytes after consumption of a low (1.3 mg/kg bw per day, 5 days) and a high dose (6.5 mg/kg bw per day, 5 days) of GTE in COMET assays (n = 5 animals per group). In addition, immunological parameters (TNF-alpha, IFN-gamma, IL-4 and IL-10), the total AO capacity and oxidized low-density lipoproteins were determined in plasma. RESULTS No evidence for reduction in DNA damage was found with a lower dose, whereas with the higher dose, reduction in DNA migration attributable to formamidopyrimidine-DNA-glycosylase sensitive lesions (oxidized purines) and endonuclease III-sensitive sites (oxidized pyrimidines) (58 and 73%) was observed in lymphocytes; also, in colonocytes (reduction in FPG-sensitive sites by 46%) and hepatocytes (decrease in Endo III-sensitive sites by 74%) protective effects were found, while none of the other parameters was altered. CONCLUSIONS Our results show that a dose of GTE, which is equivalent to consumption of 500 ml GT/p/day in humans protects lymphocytes and to a lesser extent inner organs against oxidative DNA damage, while no effect was seen with a lower dose corresponding to an uptake of 100 ml/p/day.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
November 1995, Japanese journal of cancer research : Gann,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
February 2016, Molecular medicine reports,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
January 2010, Pakistan journal of pharmaceutical sciences,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
June 2012, Neurotoxicology,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
January 2005, Pharmacological research,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
January 2015, Neurotoxicology and teratology,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
July 2011, International journal of health sciences,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
March 1998, Free radical research,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
January 2022, Folia morphologica,
Nina Kager, and Franziska Ferk, and Michael Kundi, and Karl-Heinz Wagner, and Miroslav Misík, and Siegfried Knasmüller
May 2017, Journal of advanced research,
Copied contents to your clipboard!